Xduce Technologies Acquires Further 9% Stake in Dev Information Technology from Promoters

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Xduce Technologies Boosts Stake in Dev IT, Acquires Additional 9% from Promoters

Bulk deals on March 2

M

Moneycontrol•02-03-2026, 20:39

Xduce Technologies Boosts Stake in Dev IT, Acquires Additional 9% from Promoters

•US-based Xduce Technologies acquired an additional 9.09% stake in Dev Information Technology from promoters via open market transactions on March 2.
•The acquisition involved 51.25 lakh shares at Rs 23.33 per share, totaling Rs 11.95 crore.
•Promoters Pranav Niranjan Pandya, Kruti Pranav Pandya, and Jaimin Jagdishbhai Shah collectively offloaded a 9.03% stake for Rs 11.86 crore.
•Dev Information Technology shares rallied 3.75% to Rs 24.08 following the deal, amid a market correction.
•Xduce Technologies previously held a 12.48% equity stake in Dev Information, aligning with a strategic alliance for growth in North America.

Read Full Article on Moneycontrol in English

✦

More like this

✦

More like this

Motilal Oswal Recommends MTAR Technologies: 31% Upside on Data Center Theme

Motilal Oswal Recommends MTAR Technologies: 31% Upside on Data Center Theme

Thermax Acquires 51% Stake in Exactspace for ₹30 Crore, Boosts AI-IoT Capabilities

Thermax Acquires 51% Stake in Exactspace for ₹30 Crore, Boosts AI-IoT Capabilities

Bulk Deals on March 12

Smallcap World Fund Boosts Shaily Engineering Stake by 2% for Rs 177 Cr

Shareholders who had shares of Adani Enterprises as of Friday's closing, will be eligible to participate in the rights issue, which will open for subscription on Tuesday, November 25, and close on Wednesday, December 10, 2025. Those who buy shares of the company today, will not be eligible to participate in the rights issue.

Adani arm completes full acquisition of DP Jain TOT Toll Roads

Bulk Deals on March 18

Ashish Kacholia Sells Stakes in Cosmic CRF, Exits BEW Engineering

OneSource Specialty Pharma को National Stock Exchange of India Limited और BSE Limited से ड्राफ्ट कंपोजिट स्कीम ऑफ अरेंजमेंट और अमलगमेशन (विलय) के संबंध में No Objection / No Adverse Observation Letter प्राप्त हुआ है. यह प्रस्तावित योजना Steriscience Specialties Private Limited, Brooks Steriscience Limited, Steriscience Pte. Limited, Strides Pharma Services Private Limited और Onesource Specialty Pharma Limited के बीच विलय से संबंधित है.

Tech Mahindra Subsidiary Acquires Midad's 20% Stake in TMAL for ₹206 Crore